← Back to Search

Tax Strategies for Smoking Behavior

N/A
Recruiting
Led By Warren K Bickel, Ph.D.
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be at least 21 years of age (the legal age to purchase tobacco)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will study how different taxes on tobacco products affects what people buy.

Who is the study for?
This trial is for adults over 21 who smoke at least 5 cigarettes daily and use other tobacco products less than weekly. Participants must provide a breath sample showing high carbon monoxide levels, indicating recent smoking, and consent to join the study. Pregnant or breastfeeding individuals, those on smoking cessation meds recently, or with uncontrolled health issues can't participate.Check my eligibility
What is being tested?
The study examines how four different tax proposals affect people's tobacco buying habits. These include taxes based on parity with other tobacco products, nicotine content, harm reduction potential of the product, and whether it's marketed as a modified risk tobacco product.See study design
What are the potential side effects?
Since this trial involves no medical interventions but rather behavioral observations related to purchasing patterns under different tax conditions, there are no direct side effects from participating in this research.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Poly-tobacco purchasing
Quantity of Tobacco Products Purchased in the High-Tax Tier - Product demand (intensity and elasticity)
Quantity of Tobacco Products Purchased in the Medium- and No-tax tiers - Product substitution (intensity and slope)

Trial Design

4Treatment groups
Experimental Treatment
Group I: Cigarette smokers - Tobacco ParityExperimental Treatment2 Interventions
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the Tobacco Parity Tax Condition described in the intervention section.
Group II: Cigarette smokers - Nicotine-ContentExperimental Treatment2 Interventions
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the Nicotine-Content Tax Condition described in the intervention section.
Group III: Cigarette smokers - Modified Risk Tobacco Products (MRTP)Experimental Treatment2 Interventions
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the MRTP Tax Condition described in the intervention section.
Group IV: Cigarette smokers - Harm-ReductionExperimental Treatment2 Interventions
Exclusive cigarette smokers will be recruited and will be exposed to the control condition and the Harm-ReductionTax Condition described in the intervention section.

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
142 Previous Clinical Trials
27,477 Total Patients Enrolled
Roswell Park Cancer InstituteOTHER
402 Previous Clinical Trials
30,527 Total Patients Enrolled
Warren K Bickel, Ph.D.Principal InvestigatorFralin Biomedical Research Institute at VTC
5 Previous Clinical Trials
744 Total Patients Enrolled

Media Library

Tobacco Parity Tax Condition Clinical Trial Eligibility Overview. Trial Name: NCT05370313 — N/A
Smoking/Cigarette Smoking Research Study Groups: Cigarette smokers - Tobacco Parity, Cigarette smokers - Nicotine-Content, Cigarette smokers - Harm-Reduction, Cigarette smokers - Modified Risk Tobacco Products (MRTP)
Smoking/Cigarette Smoking Clinical Trial 2023: Tobacco Parity Tax Condition Highlights & Side Effects. Trial Name: NCT05370313 — N/A
Tobacco Parity Tax Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05370313 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for participants in this research endeavor?

"The clinicaltrials.gov database reveals that, while this trial is not currently recruiting any new patients (it was initially posted on December 1st 2022 and last updated on May 6th 2022), there are 47 other trials actively enrolling volunteers at the present time."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Impact of Innovative Tax Proposals on Purchase Patterns
Warren K. Bickel 2023. "The Impact of Innovative Tax Proposals on Purchase Patterns". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05370313.
~70 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top